MedTrace Logo

Perioperatively Assessed Biomarker I-FABP Level for Prediction of Acute Mesenteric Ischemia and Its Correlation With Acute Kidney Injury, Followed by Extracorporeal Circulation (aMIKI)

NCT06365827 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-04-11

No results posted yet for this study

Summary

Acute mesenteric ischemia (AMI) is a severe condition that might occur after cardiovascular surgery. Several risk factors for AMI, such as multimorbidity, the use of vasopressors, and an increase in inflammatory markers have been identified in the past. However, these risk factors also seem to influence the blood and urine levels of I-FABP. This prospective pilot study intends to evaluate the value of perioperatively assessed I-FABP levels and to correlate these values with clinical or angiographic findings in mesenteric ischemia to improve a standardised diagnosis.

Conditions

  • Cardiac Surgery With Cardiopulmonary Bypass
  • Acute Mesenteric Ischemia
  • Acute Kidney Injury
  • Non-Occlusive Mesenteric Ischaemia

Interventions

OTHER

observational study

no intervention of interest

Sponsors & Collaborators

  • University of Giessen

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06365827 on ClinicalTrials.gov